Study the association of circulating level of Irisin with the anthropometric and metabolic parameters in normal weight, overweight and obese children

Document Type : Original Article

Authors

1 Pediatrics department, Faculty of Medicine, Beni-Suef University, Egypt

2 Department of Physiology, Faculty of Medicine, Beni-Suef University, Egypt

Abstract

The goal of this study is to study the association of circulating level of Irisin with the anthropometric and metabolic parameters in normal weight, overweight and obese children. It’s a cross sectional study conducted on 69 children, grouped into 3 groups ; normal weight (BMI<85th), overweight (BMI≥85th), and obese group (BMI≥ 95th percentile for age and sex) (39 males and 30 females), (20 normal weight, 13 overweight, 36 obese children). aged 6-18 years. All are  recruited from Endocrinology Pediatric clinic in Beni Suef University. All participants were subjected to history taking and clinical examination, anthropometric assessment (weight, height, pubertal assessment, waist circumference and hip circumference) and laboratory tests (Serum Irisin, serum cholesterol, serum high density lipoprotein, serum triglycerides, serum fasting insulin, serum fasting glucose, oral glucose tolerance test). Insulin resistance and sensitivity were assessed by calculating HOMA-IR. The obese group of 36 children (52.2%) had a higher level of Irisin than the normal weight and the overweight groups (P-value<0.001). The obese group had a significant higher prevalence of metabolic syndrome regarding the MSC Cook's and the MSC deFerranti criteria. The obese group had a significant linear positive correlation between the Irisin level and BP, BMI, cholesterol level, fasting insulin, fasting glucose, the number of criteria of Metabolic Syndrome as regards International Diabetic Federation and the HOMA IR score. Results revealed that Irisin as well as HOMA-IR can predict presence of metabolic syndrome with high sensitivity and specificity at different levels.

Keywords

Main Subjects

References

  1. Han JC, Lawlor DA, Kimm SYS. Childhood obesity. Lancet 2010;375:1737-1748.
  2. Lee EB. Obesity, leptin, and Alzheimer′s disease. Ann N Y Acad Sci 2011;1243:15-29.  
  3. Skinner A.C., Perrin E.M., Moss L.A., and Skelton J.A. Cardiometabolic risks and severity of obesity in children and young adults. N Engl J Med. 2015; 373: 1307–1317
  4. Sawyer M.G., Harchak T., Wake M., and Lynch J. Four-year prospective study of BMI and mental health problems in young children. Pediatrics. 2011; 128: 677–684
  5. Sorof J. and Daniels S. Obesity hypertension in children: a problem of epidemic proportions. Hypertension. 2002; 40: 441–447
  6. Friedemann C., Heneghan C., Mahtani K., Thompson M., Perera R., and Ward A.M. Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis. BMJ. 2012; 345: e4759
  7. Crowley D.I., Khoury P.R., Urbina E.M., Ippisch H.M., and Kimball T.R. Cardiovascular impact of the pediatric obesity epidemic: higher left ventricular mass is related to higher body mass index. J Pediatr. 2011; 158: 709–714.e1
  8. Kaufman F.R., Hirst K., Linder B. et al., HEALTHY Study Group. Risk factors for type 2 diabetes in a sixth- grade multiracial cohort: the HEALTHY study. Diabetes Care. 2009; 32: 953–955
  9. Zeitler P., Hirst K., Pyle L. et al. TODAY Study Group. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012; 366: 2247–2256
  10. Spilsbury J.C., Storfer-Isser A., Rosen C.L., and Redline S. Remission and incidence of obstructive sleep apnea from middle childhood to late adolescence. Sleep. 2015; 38: 23–29
  11. Verhulst S.L., Schrauwen N., Haentjens D. et al. Sleep-disordered breathing in overweight and obese children and adolescents: prevalence, characteristics and the role of fat distribution. Arch Dis Child. 2007; 92: 205–208
  12. Papoutsakis C., Priftis K.N., Drakouli M. et al. Childhood overweight/obesity and asthma: is there a link? A systematic review of recent epidemiologic evidence. J Acad Nutr Diet. 2013; 113: 77–105
  13. Feldstein A.E., Charatcharoenwitthaya P., Treeprasertsuk S., Benson J.T., Enders F.B., and Angulo P. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut. 2009; 58: 1538–1544
  14. Pomerantz W.J., Timm N.L., and Gittelman M.A. Injury patterns in obese versus nonobese children presenting to a pediatric emergency department. Pediatrics. 2010; 125: 681–685
  15. Yosipovitch G., DeVore A., and Dawn A. Obesity and the skin: skin physiology and skin manifestations of obesity. (quiz 917-920)J Am Acad Dermatol. 2007; 56: 901–916
  16. Legro R.S., Arslanian S.A., Ehrmann D.A...., and Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013; 98: 4565–4592
  17. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome—a new worldwide definition. Lancet 2005; 366: 1059–1062.
  18. Nagy P, Kovacs E, Moreno LA, Veidebaum T, Tornaritis M, Kourides Y et al. Percentile reference values for anthropometric body composition indices in European children from the IDEFICS study. Int J Obes (Lond) 2014; 38(Suppl 2): S15–S25.
  19. Barba G, Buck C, Bammann K, Hadjigeorgiou C, Hebestreit A, Mårild S et al.  Blood pressure reference values for European non-overweight school children:The IDEFICS study. Int J Obes (Lond) 2014; 38(Suppl 2): S48–S56.
  20. De Henauw S, Michels N, Vyncke K, Hebestreit A, Russo P, Intemann T et al. Blood lipids among young children in Europe: results from the European IDEFICS study. Int J Obes (Lond) 2014; 38(Suppl 2): S67–S75.
  21. Peplies J, Jiménez-Pavón D, Savva SC, Buck C, Günther K, Fraterman A et al. Percentiles of fasting serum insulin, glucose, HbA1c and HOMA-IR in prepubertal normal-weight European children from the IDEFICS cohort. Int J Obes (Lond) 2014; 38(Suppl 2): S39–S47.
  22. Boström P, Wu J, JedrychowskiMP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463–468.
  23. Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, Belen Crujeiras A, Seoane LM, Casanueva FF, Pardo M. FNDC5/ irisin is not only a myokine but also an adipokine. PLoS One 2013; 8:e60563.
  24. Aydin S., Koluglu T., Aydin S., Kalayci M., Yilmaz M., Cakmak T., et al. A comprehensive immuno-histochemical examination of the distribution of the fat-burning protein irisin in biological tissues Peptides, 61 (2014), pp. 130-136
  25. Wrann C.D, White J.P, Salogiannnis J, Laznik B.D, Wu J, Ma D, Lin J.D, Greenberg M.E, Spiegelman B.M. Exercise induces hippocampal BDNF through a PGC-1alpha/FNDC5 pathway. Cell Metab. 2013, 18, 649–659.
  26. Rana KS, Arif M, Hill EJ, Aldred S, Nagel DA, Nevill A, Randeva HS, Bailey CJ, Bellary S, Brown JE. Plasma irisin levels predict telomere length in healthy adults. Age (Dordr) 2014; 36: 995-1001.
  27.  Choi K. M., “The impact of organokines on insulin resistance, inflammation, and atherosclerosis,” Endocrinology and Metabolism, vol. 31, no. 1, pp. 1–6, 2016.
  28. Park M.J, Kim D.I, Choi J.H, Heo Y.R, Park S.H. New role of irisin in hepatocytes: The protective effect of hepatic steatosis in vitro. Cell Signal. 2015, 27, 1831-1839.
  29. Schiaffino S, Dyar KA, Ciciliot S, Blaauw B, Sandri M. Mechanisms regulating skeletal muscle growth and atrophy. FEBS J 2013; 280 : 4294 – 4314.
  30. Hecksteden A, Wegmann M, Steffen A, Kraushaar J, Morsch A, Ruppenthal S et al.  Irisin and exercise training in humans — Results from a randomized controlled training trial. BMC Med 2013; 11: 235.
  31. Ghali I, Salah N, Hussien F, Erfan M, El-Ruby M, Mazen I, Sabry M, Abd El-Razik M, Saad M, Hossney S, Ismaail and Abd El-Dayem S. Egyptian growth curves for infants, children and adolescents. Published in: Crecerenelmondo. Satorio A, Buckler JMH and Marazzi N (2008), Ferring Publisher, Italy
  32. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 2003; 157: 821–827.
  33. De Ferranti SD, Gauvreau K, Ludwig DN, Neufeld EJ and Newburger JW. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation; Vol. 110: pp2494-2497.
  34. Zimmet P, Alberti KG, Kaufman F, et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes. 2007;8(5):299–306.
  35. Inoue DS, De Mello MT, Foschini D, et al. Linear and undulating periodized strength plus aerobic training promote similar benefits and lead to improvement of insulin resistance on obese adolescents. J Diabetes Complicat. 2015;29(2):258–64.
  36. Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, Mantzoros CS. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012, 61 (12): 1725-38. 10.1016/j.metabol.2012.09.002
  37. Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, Klapp BF. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity–correlation with body mass index. Peptides. 2013, 39: 125-30.
  38. Pardo M, Crujeiras AB, Amil M, Aguera Z, Jimenez-Murcia S, Banos R, Botella C, de la Torre R, Estivill X, Fagundo AB, Fernandez-Real JM, Fernandez-Garcia JC, Fruhbeck G, Gomez-Ambrosi J, Rodriguez R, Tinahones FJ, Fernandez-Aranda F, Casanueva FF. (2014): Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index. Int J Endocrinol. 2014, 2014: 857270-
  39. Park KH, Zaichenko L, Peter P, Davis CR, Crowell JA, Mantzoros CS. Diet quality is associated with circulating C-reactive protein but not irisin levels in humans. Metabolism. 2014, 63 (2): 233-41. 10.1016/j.metabol.2013.10.011
  40. Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, Ricart W, Fernandez-Real JM. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 2013;98:E769-78.
  41. Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, Lee WK, Kim JG, Lee IK, Park KG. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract. 2013, 100 (1): 96-101. 10.1016/j.diabres.2013.01.007
  42. Sanchis-Gomar F, Alis R, Pareja-Galeano H, Sola E, Victor VM, Rocha M, Hernandez-Mijares A, Romagnoli M. Circulating irisin levels are not correlated with BMI, age, and other biological parameters in obese and diabetic patients. Endocrine. 2014, 46 (3): 674-7. 10.1007/s12020-014-0170-9
  43. De la Iglesia R, Lopez-Legarrea P, Crujeiras AB, Pardo M, Casanueva FF, Zulet MA, Martinez JA. Plasma irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients. Clin Endocrinol (Oxf ) 2014;81:306-11.
  44. Crujeiras AB, Pardo M, Arturo RR, Navas-Carretero S, Zulet MA, Martinez JA, Casanueva FF. Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women. Am J Hum Biol. 2014, 26 (2): 198-207. 10.1002/ajhb.22493

 

 

Files

Share

How to cite

Statistics